Scientific contributions consist of findings presented at conferences and initial results published in peer-reviewed journals, enhancing Europe’s knowledge base on gastric cancer. Outreach efforts included a consortium meeting with 50 members, a conference with 84 in-person attendees and 11 online participants, and an outreach meeting featuring around 40 specialists, which facilitated feedback from stakeholders and EU representatives regarding project findings and applications.
Validated methodologies were achieved through WP3 (Evaluation), confirming the reliability of pilot studies, while early results from WP4 (Pilot studies) demonstrated adaptable screening methods suitable for diverse EU settings.
As we move forward, we have identified and are addressing risks, considering potential adjustments, and remain confident in meeting the project's planned objectives within the designated timeframe.
In conclusion, we would like to remind you that the achieved results pertain to the first 18-month period of the project and do not include the subsequent conference in September 2024.